Ameritas Investment Company’s Vertex Pharmaceuticals VRTX Stock Holding History

Ameritas Investment Company’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-340	Closed	-$73.1K	–	2051
2021 Q1	$73.1K	Buy	+340	New	+$74.7K	0.01%	852
2020 Q4	–	Sell	-4,822	Closed	-$1.4M	–	445
2020 Q3	$1.4M	Hold	4,822	–	–	0.44%	57
2020 Q2	$1.4M	Buy	4,822 +4,521	+1,502%	+$1.23M	0.4%	60
2020 Q1	$72K	Buy	301 +190	+171%	+$43.6K	0.01%	584
2019 Q4	$24K	Buy	111 +2	+2%	+$405	0.01%	670
2019 Q3	$18K	Buy	+109	New	+$19.3K	﹤0.01%	965
2019 Q1	–	Sell	-1,395	Closed	-$231K	–	1765
2018 Q4	$231K	Buy	+1,395	New	+$242K	0.05%	271

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ameritas Investment Company's VRTX Position: Q2 2021 in Review

Ameritas Investment Company sold out of Vertex Pharmaceuticals (VRTX) in Q2 2021, closing a stake of 340 shares — an estimated $73.1K sold.

Ameritas Investment Company first reported a position in VRTX in Q4 2018 and held it in 7 quarters. The position peaked at $1.4M in Q3 2020. 977 funds tracked by Wall St. Rank hold VRTX as of Q2 2021.

Ameritas Investment Company reported no remaining Vertex Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Ameritas Investment Company sold 340 Vertex Pharmaceuticals shares in Q2 2021, an estimated $73.1K.
Ameritas Investment Company first reported a position in Vertex Pharmaceuticals in Q4 2018 and held it in 7 quarters.
Ameritas Investment Company's Vertex Pharmaceuticals position peaked at $1.4M in Q3 2020.
977 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.